DT
HealthMore in Health→
Researchers find mRNA cancer vaccines can still rally tumor-killing immunity without a presumed key cell
Key Takeaways
- Researchers tested mRNA cancer vaccination in mice.
- Strong anti-tumor responses persisted even without a dendritic-cell subtype thought essential.
- The study points to an alternate dendritic-cell pathway that could inform vaccine design.
DE
DT Editorial Team··via medicalxpress.com